Header

UZH-Logo

Maintenance Infos

Gamma-hydroxybutyrate accelerates functional recovery after focal cerebral ischemia


Gao, B; Kilic, E; Baumann, C R; Hermann, D M; Bassetti, C L (2008). Gamma-hydroxybutyrate accelerates functional recovery after focal cerebral ischemia. Cerebrovascular Diseases, 26(4):413-419.

Abstract

BACKGROUND AND PURPOSE: gamma-Hydroxybutyrate (GHB), a natural metabolite of gamma-aminobutyric acid and a drug used in humans to promote slow-wave sleep and treat narcolepsy, has been suggested to protect against ischemic stroke at high doses. This study aimed to assess recovery-promoting effects of GHB at a low dose similar to that used in patients. METHODS: Adult mice, subjected to 30 min of intraluminal middle cerebral artery occlusion, were intraperitoneally treated with GHB (100 mg/kg, twice/day, 8 h apart) or saline for 10 days. Motor recovery was evaluated by the grip strength test. The brain lesion was assessed by cresyl violet and NeuN staining 5 weeks after stroke. Expression of neuroplasticity-related genes (GAP43, c-jun, neurocan and ephrin B1) was analyzed by Taqman real-time PCR. RESULTS: GHB-treated mice regained their body weight faster and recovered grip strength (3 weeks after stroke) more quickly than saline-treated mice. This was noteworthy as GHB did not influence ischemia-induced brain injury, as revealed by cresyl violet and neuronal staining. The Taqman PCR assay revealed a decreased expression of c-jun and neurocan in the ischemic striatum of GHB-treated mice in comparison to saline-treated mice. CONCLUSION: GHB at a low dose accelerates neurological recovery following ischemic stroke. Further studies are necessary to determine the potential relationship between GHB, neuroplasticity, sleep and stroke recovery.

Abstract

BACKGROUND AND PURPOSE: gamma-Hydroxybutyrate (GHB), a natural metabolite of gamma-aminobutyric acid and a drug used in humans to promote slow-wave sleep and treat narcolepsy, has been suggested to protect against ischemic stroke at high doses. This study aimed to assess recovery-promoting effects of GHB at a low dose similar to that used in patients. METHODS: Adult mice, subjected to 30 min of intraluminal middle cerebral artery occlusion, were intraperitoneally treated with GHB (100 mg/kg, twice/day, 8 h apart) or saline for 10 days. Motor recovery was evaluated by the grip strength test. The brain lesion was assessed by cresyl violet and NeuN staining 5 weeks after stroke. Expression of neuroplasticity-related genes (GAP43, c-jun, neurocan and ephrin B1) was analyzed by Taqman real-time PCR. RESULTS: GHB-treated mice regained their body weight faster and recovered grip strength (3 weeks after stroke) more quickly than saline-treated mice. This was noteworthy as GHB did not influence ischemia-induced brain injury, as revealed by cresyl violet and neuronal staining. The Taqman PCR assay revealed a decreased expression of c-jun and neurocan in the ischemic striatum of GHB-treated mice in comparison to saline-treated mice. CONCLUSION: GHB at a low dose accelerates neurological recovery following ischemic stroke. Further studies are necessary to determine the potential relationship between GHB, neuroplasticity, sleep and stroke recovery.

Statistics

Citations

24 citations in Web of Science®
27 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

25 downloads since deposited on 17 Dec 2008
13 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:28 August 2008
Deposited On:17 Dec 2008 12:19
Last Modified:07 Jul 2016 07:21
Publisher:Karger
ISSN:1015-9770
Publisher DOI:https://doi.org/10.1159/000151683
PubMed ID:18753748

Download

Download PDF  'Gamma-hydroxybutyrate accelerates functional recovery after focal cerebral ischemia'.
Preview
Content: Published Version
Filetype: PDF
Size: 1MB
View at publisher
Download PDF  'Gamma-hydroxybutyrate accelerates functional recovery after focal cerebral ischemia'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 1MB